Expert Opinion On Therapeutic Patents

杂志介绍

Expert Opinion On Therapeutic Patents杂志介绍

《Expert Opinion On Therapeutic Patents》是一本以English为主的未开放获取国际优秀期刊，中文名称治疗性专利专家意见，本刊主要出版、报道医学-CHEMISTRY, MEDICINAL领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为5.4，最新CiteScore 指数为12.1。

本刊近期中国学者发表的论文主要有：

• Novel diarylpyrimidines and diaryltriazines as potent HIV-1 NNRTIs with dramatically improved solubility: a patent evaluation of US20140378443A1.

  Author: Huang B, Kang D, Yang J, Zhan P, Liu X.

• RGD mimetics γ-AApeptides and methods of use (US 20,140,004,039 A1): a patent evaluation.

  Author: Wu H, Jiang J, Xu H, Li Q, Cai J.

• Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).

  Author: Yang Y, An S, Liu Y, Guo XX, Gao L, Wei JF, Xu TR.

• Analysis of anti-asthmatic drug patents published in China between 2004 and 2013.

  Author: Xie H, Zhang H, Cao K, He P, Dai H, He S.

英文介绍

Expert Opinion On Therapeutic Patents杂志英文介绍

Expert Opinion on Therapeutic Patents (ISSN 1354-3776 [print], 1744-7674 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles on recent pharmaceutical patent claims, providing expert opinion the scope for future development, in the context of the scientific literature.

The Editors welcome:

Reviews covering recent patent claims on compounds or applications with therapeutic potential, including biotherapeutics and small-molecule agents with specific molecular targets; and patenting trends in a particular therapeutic area

Patent Evaluations examining the aims and chemical and biological claims of individual patents

Perspectives on issues relating to intellectual property

The audience consists of scientists, managers and decision-makers in the pharmaceutical industry and others closely involved in R&D

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days.